Search Results - "ARCESE, W"

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies by Noguera, N., Catalano, G., Banella, C., Divona, M., Faraoni, I., Ottone, T., Arcese, W., Voso, M.

“…This review highlights new findings that have deepened our understanding of the mechanisms of leukemogenesis, therapy and resistance in acute promyelocytic…”
Get full text

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia by Ruggeri, A, Labopin, M, Sanz, G, Piemontese, S, Arcese, W, Bacigalupo, A, Blaise, D, Bosi, A, Huang, H, Karakasis, D, Koc, Y, Michallet, M, Picardi, A, Sanz, J, Santarone, S, Sengelov, H, Sierra, J, Vincent, L, Volt, F, Nagler, A, Gluckman, E, Ciceri, F, Rocha, V, Mohty, M

“…Outcomes after unmanipulated haploidentical stem cell transplantation (Haplo) and after unrelated cord blood transplantation (UCBT) are encouraging and have…”
Get full text

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia by Piemontese, Simona, Ciceri, F, Labopin, M, Arcese, W, Kyrcz-Krzemien, S, Santarone, S, Huang, H, Beelen, D, Gorin, N C, Craddock, C, Gulbas, Z, Bacigalupo, A, Mohty, M, Nagler, A

“…In the absence of a HLA-matched related or matched unrelated donor, allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or…”
Get full text

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper by Sarmati, L., Andreoni, M., Antonelli, G., Arcese, W., Bruno, R., Coppola, N., Gaeta, G.B., Galli, M., Girmenia, C., Mikulska, M., Pane, F., Perno, C.F., Picardi, M., Puoti, M., Rambaldi, A., Svicher, V., Taliani, G., Gentile, G.

“…Hepatitis B virus (HBV) infection reactivation is associated with high morbidity and mortality in patients with haematologic malignancy and/or haematopoietic…”
Get full text

Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings? by Ringdén, O, Labopin, M, Ciceri, F, Velardi, A, Bacigalupo, A, Arcese, W, Ghavamzadeh, A, Hamladji, R M, Schmid, C, Nagler, A, Mohty, M

“…Haploidentical hematopoietic stem cell transplants (HSCTs) are increasingly used, but it is unknown whether they have a stronger graft-versus-leukemia (GVL)…”
Get full text

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia by Alfonso, V., Iaccarino, L., Ottone, T., Cicconi, L., Lavorgna, S., Divona, M., Cairoli, R., Cristiano, A., Ciardi, C., Travaglini, S., Falconi, G., Hasan, S. K., Venditti, A., Arcese, W., Voso, M. T., Lo-Coco, F.

Get full text

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation by Domingo-Domenech, E., Duarte, R. F., Boumedil, A., Onida, F., Gabriel, I., Finel, H., Arcese, W., Browne, P., Beelen, D., Kobbe, G., Veelken, H., Arranz, R., Greinix, H., Lenhoff, S., Poiré, X., Ribera, J. M., Thompson, J., Zuckerman, T., Mufti, G. J., Cortelezzi, A., Olavarria, E., Dreger, P., Sureda, A., Montoto, S.

“…Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option in advanced-stage mycosis fungoides (MF)…”
Get full text

Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study by Marchesi, F, Tendas, A, Giannarelli, D, Viggiani, C, Gumenyuk, S, Renzi, D, Franceschini, L, Caffarella, G, Rizzo, M, Palombi, F, Pisani, F, Romano, A, Spadea, A, Papa, E, Canfora, M, Pignatelli, A, Cantonetti, M, Arcese, W, Mengarelli, A

Get full text

Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT by Ruggeri, A, Sanz, G, Bittencourt, H, Sanz, J, Rambaldi, A, Volt, F, Yakoub-Agha, I, Ribera, J M, Mannone, L, Sierra, J, Mohty, M, Solano, C, Nabhan, S, Arcese, W, Gluckman, E, Labopin, M, Rocha, V

“…We report outcomes after single (s) and double (d) umbilical cord blood transplantation (UCBT) after myeloablative conditioning (MAC) regimen for 239 patients…”
Get full text

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia by Piemontese, S, Ciceri, F, Labopin, M, Bacigalupo, A, Huang, H, Santarone, S, Gorin, N-C, Koc, Y, Wu, D, Beelen, D, Tischer, J, Ehninger, G, Arcese, W, Nagler, A, Mohty, M

“…The use of unmanipulated graft is increasingly adopted in the setting of allogeneic hematopoietic stem cell transplantation from haploidentical family donors…”
Get full text

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission by Saraceni, F, Bruno, B, Lemoli, R M, Meloni, G, Arcese, W, Falda, M, Ciceri, F, Alessandrino, E P, Specchia, G, Scimè, R, Raimondi, R, Bacigalupo, A, Bosi, A, Onida, F, Rambaldi, A, Bonifazi, F, Olivieri, A

Get full text

Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) by Todisco, E, Ciceri, F, Boschini, C, Giglio, F, Bacigalupo, A, Patriarca, F, Donnini, I, Alessandrino, E P, Arcese, W, Iori, A P, Marenco, P, Cavattoni, I, Chiusolo, P, Terruzzi, E, Castagna, L, Santoro, A, Bosi, A, Oldani, E, Bruno, B, Bonifazi, F, Rambaldi, A

“…The clinical outcome of primary refractory (PRF) AML patients is poor and only a minor proportion of patients is rescued by allogenic hematopoietic stem cell…”
Get full text

Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation by Marchand, T, Lamy, T, Finel, H, Arcese, W, Choquet, S, Finke, J, Huynh, A, Irrera, G, Karakasis, D, Konopacki, J, Lambert, J, Michieli, M, Schouten, H C, Schroyens, W, Sucak, G, Tischer, J, Vandenberghe, E, Dreger, P

“…Letter to the Editor. Large granular lymphocyte (LGL) leukemia is a rare lymphoproliferative disorder characterized by clonal expansion of either CD3+…”
Get full text

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor by Cerva, C., Colagrossi, L., Maffongelli, G., Salpini, R., Di Carlo, D., Malagnino, V., Battisti, A., Ricciardi, A., Pollicita, M., Bianchi, A., Picardi, A., Cudillo, L., Cerretti, R., De Angelis, G., Cantonetti, M., Andreoni, M., Perno, C.F., Arcese, W., Svicher, V., Sarmati, L.

“…The overall rate of hepatitis B virus (HBV) reactivation was evaluated in a population of 373 haematological stem cell transplant (HSCT) patients treated with…”
Get full text

Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update by Arcese, W, Picardi, A, Santarone, S, De Angelis, G, Cerretti, R, Cudillo, L, Pennese, E, Bavaro, P, Olioso, P, Dentamaro, T, Cupelli, L, Chierichini, A, Ferrari, A, Mengarelli, A, Tirindelli, M C, Testi, M, Di Piazza, F, Di Bartolomeo, P

“…Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unmanipulated bone marrow (BM) transplantation from a related,…”
Get full text

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia by Buccisano, F, Maurillo, L, Piciocchi, A, Del Principe, M I, Picardi, A, Cerretti, R, Cudillo, L, De Angelis, G, Sarlo, C, Cefalo, M, Ditto, C, Di Veroli, A, Mariotti, B, Nasso, D, De Bellis, E, Del Poeta, G, Voso, M T, Sconocchia, G, Lo Coco, F, Arcese, W, Amadori, S, Venditti, A

Get full text

Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT by Kharfan-Dabaja, M A, Labopin, M, Bazarbachi, A, Hamladji, R M, Blaise, D, Socié, G, Lioure, B, Bermudez, A, Lopez-Corral, L, Or, R, Arcese, W, Fegueux, N, Nagler, A, Mohty, M

“…This retrospective analysis compared two regimens of fludarabine combined with i.v. BU 6.4 mg/kg (FB2) or BU 12.8 mg/kg (FB4) for allografting of AML in first…”
Get full text

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis by Cunha, R, Loiseau, P, Ruggeri, A, Sanz, G, Michel, G, PaolaIori, A, Socié, G, Arcese, W, Picardi, A, Dias de Heredia, C, Rio, B, Locatelli, F, O'Brien, T A, Yakoub-Agha, I, Angel Diaz, M, Milpied, N, Bittencourt, H, Pedro Souza, M, Aljurf, M, Charron, D, Boudjedir, K, Labopin, M, Gluckman, E, Rocha, V

“…HLA matching is a critical determinant of outcomes for patients who have undergone umbilical cord blood transplantation (UCBT). Data have been published on the…”
Get full text

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo by Todisco, E, Ciceri, F, Oldani, E, Boschini, C, Micò, C, VanLint, M T, Donnini, I, Patriarca, F, Alessandrino, P E, Bonifazi, F, Arcese, W, Barberi, W, Marenco, P, Terruzzi, E, Cortelazzo, S, Santarone, S, Proia, A, Corradini, P, Tagliaferri, E, Falcioni, S, Irrera, G, Dallanegra, L, Castagna, L, Santoro, A, Camboni, A, Sacchi, N, Bosi, A, Bacigalupo, A, Rambaldi, A

Get full text

Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant by Mengarelli, A, Annibali, O, Pimpinelli, F, Riva, E, Gumenyuk, S, Renzi, D, Cerchiara, E, Piccioni, L, Palombi, F, Pisani, F, Romano, A, Spadea, A, Papa, E, Cordone, I, Canfora, M, Arcese, W, Ensoli, F, Marchesi, F

Get full text